This archive contains the following articles listed by volume, issue and page number:
 |
|
|
| MARKETING RELATED ARTICLES |
| Title (Click for Details) |
Vol/Issue |
Page |
| Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy |
Vol. 22 No. 6 |
471 |
| Compounding from a Pharmacy Student's Perspective |
Vol. 22 No. 4 |
281 |
| Pharmacogenomics: Precision Pharmacy in 503A Compounding |
Vol. 22 No. 2 |
95 |
| Why Become Pharmacy Compounding Accreditation Board Accredited? |
Vol. 20 No. 6 |
469 |
| Bedside Manner: Not Just for Doctors Anymore |
Vol. 19 No. 2 |
115 |
| Giving Back: A Win-Win Plan of Action for Compounding Pharmacists |
Vol. 19 No. 1 |
14 |
| Marketing: Using Facebook to Market Your Compounding Pharmacy |
Vol. 18 No. 6 |
490 |
| Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy |
Vol. 18 No. 5 |
406 |
| Marketing: Effective Use of Advertisements on Your Website |
Vol. 18 No. 3 |
210 |
| Effective Advertisements |
Vol. 18 No. 2 |
120 |
| Marketing |
Vol. 18 No. 1 |
38 |
| Marketing During the Holidays |
Vol. 17 No. 6 |
482 |
| PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial |
Vol. 17 No. 3 |
262 |
| Marketing: Overcoming Objections to Prescribing Compounded Medications |
Vol. 16 No. 6 |
484 |
| Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients |
Vol. 16 No. 5 |
394 |
| Okay, I've Got It: Now What Do I Do With It? |
Vol. 16 No. 4 |
310 |
| Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy |
Vol. 16 No. 3 |
224 |
| Trade Shows: Planning Your Strategy |
Vol. 16 No. 2 |
134 |
| 7 Marketing Tactics That Don't Work |
Vol. 15 No. 5 |
388 |
| 7 Marketing Tactics That Don't Work, Part 3 |
Vol. 15 No. 4 |
320 |
| 7 Marketing Tactics That Don't Work, Part 2 |
Vol. 15 No. 3 |
222 |
| Seven Marketing Tactics That Don't Work |
Vol. 15 No. 2 |
130 |
| Marketing Vitamins, Minerals, and Other Nutrients |
Vol. 15 No. 1 |
44 |
| Home Infusion Accreditation: Another Quality Recognition Branding Tool |
Vol. 14 No. 5 |
360 |
| Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response |
Vol. 14 No. 5 |
366 |
| Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging |
Vol. 14 No. 1 |
26 |
| Compounding Pharmacy: A Unique Service for a Unique Population |
Vol. 14 No. 1 |
19 |
| Marketing the Geriatric Patient |
Vol. 13 No. 6 |
538 |
| Marketing Veterinarians |
Vol. 13 No. 5 |
410 |
| An Abridged History of Aspirin |
Vol. 13 No. 5 |
404 |
| Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study |
Vol. 13 No. 5 |
440 |
| Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing |
Vol. 13 No. 4 |
311 |
| PreScription: A Good Name: Pharmacy |
Vol. 13 No. 3 |
180 |
| Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education |
Vol. 13 No. 3 |
224 |
| Blogging for Business |
Vol. 13 No. 2 |
141 |
| Technology for the Patient-Centric Pharmacy |
Vol. 12 No. 5 |
434 |
| Marketing: Taking Your Show on the Road |
Vol. 12 No. 5 |
438 |
| Branding: Give Your Small Business a Big Image |
Vol. 12 No. 6 |
537 |
| Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization |
Vol. 12 No. 4 |
334 |
| Marketing for Your Community |
Vol. 12 No. 4 |
338 |
| Developing a Niche Marketing Strategy |
Vol. 12 No. 3 |
242 |
| Web 2.0 and Health 2.0: Are You In? |
Vol. 12 No. 3 |
244 |
| Newsletters: An Essential Marketing Tool |
Vol. 12 No. 2 |
128 |
| PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care |
Vol. 12 No. 2 |
174 |
| Websites: Keeping Current in 2008 |
Vol. 12 No. 1 |
48 |
| PostScription: Consumer Options for Disposal of Unused Medications |
Vol. 12 No. 1 |
87 |
| Standard Operating Procedure: Complaint and Mishap Rectification |
Vol. 11 No. 5 |
414 |
| Book Review: The Rexall Story: A History of Genius and Neglect |
Vol. 11 No. 4 |
300 |
| PostScription: IJPC—More Than a Journal |
Vol. 11 No. 1 |
88 |
| Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists |
Vol. 10 No. 6 |
462 |
| PreScription: Certification and Accreditation |
Vol. 10 No. 5 |
322 |
| What are You Willing to Do? |
Vol. 10 No. 4 |
287 |
| The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States |
Vol. 10 No. 3 |
175 |
| Quick Tips for Managing Market Directors |
Vol. 10 No. 3 |
201 |
| PreScription: The Squeaky Wheel Gets the Grease! |
Vol. 10 No. 2 |
82 |
| How'd They Do That? |
Vol. 10 No. 1 |
46 |
| Marketing Your Business for Success |
Vol. 9 No. 6 |
445 |
| What Customers Want |
Vol. 9 No. 3 |
213 |
| Communication Makes It or Breaks It |
Vol. 9 No. 2 |
133 |
| The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime |
Vol. 9 No. 1 |
37 |
| PostScription |
Vol. 8 No. 6 |
496 |
| A Foot in the Door: Marketing Tips - Dealing With Personalities |
Vol. 8 No. 5 |
373 |
| Case Reports: Their Impact |
Vol. 8 No. 4 |
266 |
| A Foot in the Door: Building Relationships Builds Your Business |
Vol. 8 No. 3 |
197 |
| Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. |
Vol. 8 No. 2 |
107 |
| Detailing Your Compounding Specialty Practice - Part 2: The Presentation |
Vol. 8 No. 2 |
113 |
| Financially Speaking: Business Continuation Planning |
Vol. 8 No. 2 |
120 |
| Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach |
Vol. 8 No. 1 |
31 |
| A Foot in the Door: Marketing Tips |
Vol. 7 No. 6 |
454 |
| How To Perform a Study in Your Pharmacy with Little or No Effort |
Vol. 6 No. 3 |
186 |
| Developing a Successful Compounding Business in a Small Town |
Vol. 6 No. 2 |
108 |
| A Guide to Effective Media Relations |
Vol. 6 No. 2 |
111 |
| High-tech Marketing Techniques |
Vol. 5 No. 6 |
420 |
| Formulations for Success, Part 2 |
Vol. 5 No. 4 |
287 |
| Motivation and Management: How to Build Your Business into the Job You Love |
Vol. 5 No. 3 |
166 |
| Pricing Strategies |
Vol. 5 No. 3 |
180 |
| Pediatric Compounding: Coloring Outside the Lines |
Vol. 5 No. 1 |
6 |
| Marketing Your Prescription Compounding Practice: Part Three |
Vol. 4 No. 3 |
199 |
| Marketing Your Prescription Compounding Practice: Part Two |
Vol. 4 No. 2 |
115 |
| Marketing Your Prescription Compounding Practice: Part One |
Vol. 4 No. 1 |
36 |
| Marketing Tip: Marketing Reps Can Help |
Vol. 4 No. 1 |
39 |
| Marketing Tip: Flavors: Target Marketing to Doctors and Patients |
Vol. 3 No. 6 |
454 |
| Independent Pharmacists Score High with Consumers |
Vol. 3 No. 6 |
457 |
| Planning and Marketing a Natural HRT Patient Seminar |
Vol. 3 No. 5 |
360 |
| Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars |
Vol. 3 No. 5 |
362 |
| Marketing Tip: PR Can Help with Image Change and Geographic Expansion |
Vol. 3 No. 4 |
277 |
| Marketing Tip: Teachable Moments: A Simple Concept |
Vol. 3 No. 3 |
199 |
| Marketing Tip: Locator Maps |
Vol. 3 No. 2 |
127 |
| HRT Marketing Tip |
Vol. 3 No. 1 |
37 |
| Essential Truths About HRT |
Vol. 2 No. 1 |
10 |
| Interview on HRT: Christiane Northrup, MD, FACOG |
Vol. 2 No. 1 |
12 |
| HRT and the Continuing Education of Health Care Professionals |
Vol. 2 No. 1 |
18 |
| Marketing to Veterinarians - Field Notes |
Vol. 1 No. 4 |
236 |
|
|
|
| LEGAL RELATED ARTICLES |
| Title (Click for Details) |
Vol/Issue |
Page |
| Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
|
Vol. 22 No. 6 |
475 |
| PreScription: Updating Formulations |
Vol. 22 No. 5 |
356 |
| Current Trends and Emerging Priorities in Compounded Preparations for Children |
Vol. 22 No. 5 |
358 |
| Certification of Powder-containment Hoods for Nonsterile Compounding |
Vol. 22 No. 5 |
369 |
| Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations |
Vol. 22 No. 5 |
387 |
| Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 |
Vol. 22 No. 5 |
401 |
| Your Presence is Needed at Compounders on Capitol Hill! |
Vol. 22 No. 3 |
204 |
| PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing |
Vol. 22 No. 2 |
92 |
| Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management |
Vol. 22 No. 2 |
108 |
| IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing |
Vol. 22 No. 2 |
125 |
| Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy |
Vol. 22 No. 2 |
129 |
| PreScription: 2017--Some Good Things Happened and Some Others |
Vol. 22 No. 1 |
4 |
| Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies |
Vol. 22 No. 1 |
7 |
| The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives |
Vol. 22 No. 1 |
26 |
| PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement |
Vol. 21 No. 6 |
444 |
| Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! |
Vol. 21 No. 6 |
468 |
| Validation of the Technological Process of the Preparation "Milk by Vidal" |
Vol. 21 No. 6 |
513 |
| PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs |
Vol. 21 No. 5 |
356 |
| Child-safety Containers/Devices and Compounding |
Vol. 21 No. 5 |
364 |
| Documentation: Records and Reports |
Vol. 21 No. 5 |
373 |
| IACP Legislative/Regulatory Update |
Vol. 21 No. 5 |
382 |
| The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 |
Vol. 21 No. 4 |
290 |
| PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Vol. 21 No. 3 |
180 |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Vol. 21 No. 3 |
212 |
| PreScription: Whatever Happened to Common Sense? |
Vol. 21 No. 2 |
92 |
| U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies |
Vol. 21 No. 2 |
95 |
| The International Academy of Compounding Pharmacists Introduces a New President |
Vol. 21 No. 2 |
116 |
| Quality Control: (Material) Safety Data Sheets |
Vol. 21 No. 2 |
118 |
| Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 |
Vol. 21 No. 2 |
127 |
| PreScription: Compounding Pharmacy Issues for 2017 |
Vol. 21 No. 1 |
4 |
| When to Compound Medications for Veterinary Patients |
Vol. 21 No. 1 |
19 |
| Why You Should Become an International Academy of Compounding Pharmacists Member |
Vol. 21 No. 1 |
28 |
| U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) |
Vol. 20 No. 6 |
457 |
| The "Lists": What Do They Mean? |
Vol. 20 No. 6 |
477 |
| Basics of Compounding: Clinical Pharmaceutics, Part 2 |
Vol. 20 No. 6 |
485 |
| PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals |
Vol. 20 No. 5 |
356 |
| Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy |
Vol. 20 No. 5 |
367 |
| More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! |
Vol. 20 No. 5 |
377 |
| Compounding Transdermal Medication for Feline Patients |
Vol. 20 No. 4 |
271 |
| IACP's 2016 Compounders on Capitol Hill Asks |
Vol. 20 No. 4 |
294 |
| Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding |
Vol. 20 No. 4 |
307 |
| Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines |
Vol. 20 No. 4 |
351 |
| PreScription: Patient Access to Pharmaceuticals |
Vol. 20 No. 3 |
180 |
| Compounding in Nigeria |
Vol. 20 No. 3 |
189 |
| IACP Names Voliva Executive Vice President |
Vol. 20 No. 3 |
194 |
| PreScription: Compounding: A Changing Paradigm |
Vol. 20 No. 2 |
92 |
| Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations |
Vol. 20 No. 2 |
95 |
| Microbial Identification in Pharmaceutical Compounding |
Vol. 20 No. 1 |
13 |
| Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success |
Vol. 20 No. 1 |
29 |
| PostScription: The Home Field Advantage |
Vol. 20 No. 1 |
86 |
| PreScription: The Documented Past and the Exciting Future |
Vol. 19 No. 6 |
442 |
| International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance |
Vol. 19 No. 6 |
449 |
| Applying Quality of Design Concepts to Pharmacy Compounding |
Vol. 19 No. 6 |
453 |
| U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs |
Vol. 19 No. 6 |
487 |
| The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding |
Vol. 19 No. 5 |
375 |
| The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists |
Vol. 19 No. 5 |
377 |
| Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 |
Vol. 19 No. 5 |
389 |
| PostScription: Progress Report: Provider Status Continues to Gain Strength! |
Vol. 19 No. 5 |
437 |
| PreScription: Potpourri of Opinions…From Many |
Vol. 19 No. 4 |
266 |
| U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances |
Vol. 19 No. 4 |
303 |
| Basics of Compounding: The "Negative" List |
Vol. 19 No. 4 |
311 |
| IACP Says: "Fix DQSA" |
Vol. 19 No. 3 |
212 |
| Quality Assurance and Quality Control, Part 2 |
Vol. 19 No. 3 |
215 |
| PostScription: Opportunities to Change the Pharmacy Landscape |
Vol. 19 No. 3 |
271 |
| New England Compounding Center Indictment |
Vol. 19 No. 2 |
94 |
| Standing Together Fixing the Drug Quality and Security Act |
Vol. 19 No. 2 |
104 |
| Standarized Compounding: The Importance of Doing it the Same Way Every Time |
Vol. 19 No. 2 |
109 |
| PreScription: 2014 in Review |
Vol. 19 No. 1 |
4 |
| Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance |
Vol. 19 No. 1 |
30 |
| Basics of Sterile Compounding: Aseptic Processing |
Vol. 19 No. 1 |
49 |
| Basics of Compounding: The Revised "Not to Compound List" |
Vol. 19 No. 1 |
57 |
| PostScription: Pharmacists Advancing Toward Provider Status |
Vol. 19 No. 1 |
86 |
| Compounding Legislation: Focus Shifts to States |
Vol. 18 No. 6 |
470 |
| PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future |
Vol. 18 No. 6 |
526 |
| Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A |
Vol. 18 No. 5 |
379 |
| Compounding Practices in a Portuguese Community Pharmacy |
Vol. 18 No. 5 |
392 |
| PostScription: The Future of Veterinary Compounding |
Vol. 18 No. 5 |
438 |
| PreScription: Challenging Times |
Vol. 18 No. 4 |
268 |
| Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety |
Vol. 18 No. 4 |
270 |
| Color Additives: Legislative Perspective in the United States, Europe, Australia, and India |
Vol. 18 No. 4 |
293 |
| 400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill |
Vol. 18 No. 4 |
302 |
| Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 |
Vol. 18 No. 4 |
305 |
| PreScription: Déjà Vu All Over Again |
Vol. 18 No. 3 |
180 |
| The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter |
Vol. 18 No. 3 |
208 |
| PreScription: Standards vs Opinions |
Vol. 18 No. 2 |
92 |
| Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective |
Vol. 18 No. 2 |
101 |
| Compounding Practices in Iran |
Vol. 18 No. 2 |
112 |
| IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities |
Vol. 18 No. 2 |
117 |
| PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year |
Vol. 18 No. 1 |
4 |
| Good Enough for America |
Vol. 18 No. 1 |
20 |
| U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 |
Vol. 18 No. 1 |
35 |
| Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding |
Vol. 17 No. 6 |
477 |
| HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? |
Vol. 17 No. 6 |
480 |
| Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety |
Vol. 17 No. 6 |
485 |
| PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions |
Vol. 17 No. 5 |
356 |
| Compounding Pharmacies: Before and After an Inspection |
Vol. 17 No. 5 |
358 |
| Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms |
Vol. 17 No. 5 |
364 |
| 2013 State Compounding Legislation Tracker Updated: August 12, 2013 |
Vol. 17 No. 5 |
375 |
| PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters |
Vol. 17 No. 5 |
439 |
| United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 |
Vol. 17 No. 4 |
283 |
| Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover |
Vol. 17 No. 4 |
290 |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Vol. 17 No. 4 |
302 |
| PostScription: Traditional vs Nontraditional Pharmacy |
Vol. 17 No. 4 |
351 |
| PreScription: Compounding for Drug Shortages |
Vol. 17 No. 3 |
180 |
| Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists |
Vol. 17 No. 3 |
182 |
| Decontamination Technology: The Missing Element |
Vol. 17 No. 3 |
193 |
| International Academy of Compounding Pharmacists' Legislative/Regulatory Update |
Vol. 17 No. 3 |
206 |
| Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations |
Vol. 17 No. 3 |
210 |
| Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines |
Vol. 17 No. 3 |
238 |
| PreScription: Pharmacy Committees |
Vol. 17 No. 2 |
92 |
| Compounding in Ukraine |
Vol. 17 No. 2 |
124 |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Vol. 17 No. 2 |
128 |
| PreScription: Looking for Solutions |
Vol. 17 No. 1 |
4 |
| Pediatric Health Care: An Introduction |
Vol. 17 No. 1 |
6 |
| International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives |
Vol. 17 No. 1 |
48 |
| PostScription: GMPs and GCPs: A Topical Comparison |
Vol. 17 No. 1 |
87 |
| The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act |
Vol. 16 No. 6 |
446 |
| Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis |
Vol. 16 No. 6 |
456 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 6 |
476 |
| Quality Control: Analytical Methods. Certificates of Analysis, Part 1 |
Vol. 16 No. 6 |
486 |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel |
Vol. 16 No. 6 |
490 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 5 |
382 |
| Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers |
Vol. 16 No. 4 |
294 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 4 |
300 |
| Selection of Color Additives: A Regulatory View |
Vol. 16 No. 4 |
304 |
| PreScription: You're On Your Own |
Vol. 16 No. 3 |
180 |
| PreScription: Working in Handcuffs |
Vol. 16 No. 3 |
180 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 3 |
220 |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification |
Vol. 16 No. 3 |
230 |
| The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy |
Vol. 16 No. 2 |
94 |
| Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes |
Vol. 16 No. 2 |
98 |
| PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone |
Vol. 16 No. 1 |
86 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 1 |
50 |
| PreScription: Compounding: Keeping Elephants Our of Our Mouseholes |
Vol. 15 No. 6 |
444 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 6 |
471 |
| The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire |
Vol. 15 No. 6 |
474 |
| PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse |
Vol. 15 No. 6 |
526 |
| PreScription: Third-party Inequities and Discrimination |
Vol. 15 No. 5 |
356 |
| Natural Tragedies: Planning for Disasters and Emergencies |
Vol. 15 No. 5 |
368 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 5 |
382 |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 |
Vol. 15 No. 5 |
408 |
| Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy |
Vol. 15 No. 4 |
278 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 4 |
286 |
| PreScription: Greed Does Not Pay! Makena, Lucentis, and Others |
Vol. 15 No. 3 |
180 |
| PreScription: Making Things Right--Or Not? |
Vol. 15 No. 3 |
180 |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 3 |
218 |
| Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions |
Vol. 15 No. 3 |
224 |
| PreScription: Discontinued Drugs and Drug Shortages |
Vol. 15 No. 2 |
92 |
| PreScription: Compounding with Manufactured Products |
Vol. 14 No. 6 |
448 |
| Home Infusion: Overcoming the Barriers to Entry |
Vol. 14 No. 6 |
450 |
| PreScription: Compounding Veterinary Products: Needed but Problematic |
Vol. 14 No. 5 |
358 |
| Home Infusion Accreditation: Another Quality Recognition Branding Tool |
Vol. 14 No. 5 |
360 |
| PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle |
Vol. 14 No. 4 |
268 |
| PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals |
Vol. 14 No. 4 |
268 |
| PreScription: Healthcare Reform Is Not All That Is Happening in Washington |
Vol. 14 No. 3 |
180 |
| PostScription: Healthcare Reform and Compounding Issues |
Vol. 14 No. 3 |
262 |
| Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs |
Vol. 14 No. 2 |
131 |
| PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? |
Vol. 14 No. 2 |
174 |
| Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust |
Vol. 13 No. 6 |
532 |
| An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding |
Vol. 13 No. 6 |
525 |
| Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications |
Vol. 13 No. 5 |
400 |
| PostScription: Setting up a National System of Compounding Pharmacies: An Introduction |
Vol. 13 No. 5 |
447 |
| PostScription: Compounding Pharmacy in Puerto Rico |
Vol. 13 No. 4 |
350 |
| PreScription: Electronic Prescribing |
Vol. 13 No. 2 |
92 |
| PostScription: Compounding in Argentina |
Vol. 13 No. 2 |
175 |
| PreScription: A New Start: What Will 2009 Bring? |
Vol. 13 No. 1 |
4 |
| PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective |
Vol. 13 No. 1 |
87 |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs |
Vol. 13 No. 1 |
56 |
| The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials |
Vol. 13 No. 1 |
81 |
| Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information |
Vol. 12 No. 5 |
405 |
| Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship |
Vol. 12 No. 5 |
410 |
| Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers |
Vol. 12 No. 5 |
414 |
| Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? |
Vol. 12 No. 5 |
420 |
| Prescription: Is "Globalization" a Good Idea? |
Vol. 12 No. 6 |
474 |
| Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers |
Vol. 12 No. 6 |
508 |
| Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where |
Vol. 12 No. 6 |
514 |
| PostScription: Supporting Compounding Around the World |
Vol. 12 No. 6 |
565 |
| PreScription: First Estriol, Then What? |
Vol. 12 No. 4 |
284 |
| Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada |
Vol. 12 No. 4 |
365 |
| PostScription: It Is Not Just What You Say…But How You Say It! |
Vol. 12 No. 4 |
375 |
| Estriol: Women's Choice vs. A Manufacturer's Greed |
Vol. 12 No. 4 |
286 |
| Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature |
Vol. 12 No. 4 |
329 |
| Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization |
Vol. 12 No. 4 |
334 |
| PreScription: Pain! |
Vol. 12 No. 3 |
180 |
| Litigating the Legality of Compounding: The Medical Center Pharmacy Case |
Vol. 12 No. 3 |
238 |
| Current Compounding Practices in Europe |
Vol. 12 No. 2 |
94 |
| Compounding Around the World |
Vol. 12 No. 2 |
102 |
| Establishing a Quality-Assurance Program for Hospital Compounding |
Vol. 12 No. 2 |
116 |
| Hormone Therapy: It's Time for a Second Opinion |
Vol. 12 No. 2 |
122 |
| PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care |
Vol. 12 No. 2 |
174 |
| PreScription: Year Number 12…And Still Much Work to Do |
Vol. 12 No. 1 |
4 |
| Disposing of Expired Drugs and Chemicals: New Options for Compounders |
Vol. 12 No. 1 |
38 |
| Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 |
Vol. 12 No. 1 |
63 |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations |
Vol. 12 No. 1 |
54 |
| Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists |
Vol. 12 No. 1 |
74 |
| Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study |
Vol. 11 No. 6 |
450 |
| Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds |
Vol. 11 No. 6 |
487 |
| PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 |
Vol. 11 No. 5 |
438 |
| PreScription: Bias, NAMS, and HRT |
Vol. 11 No. 4 |
266 |
| Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature |
Vol. 11 No. 4 |
269 |
| Premarin: The Intriguing History of a Controversial Drug |
Vol. 11 No. 4 |
282 |
| The Politics of Hormone Replacement Therapy |
Vol. 11 No. 4 |
278 |
| Quality-control Analytical Methods: Logbooks and Documentation Forms |
Vol. 11 No. 4 |
306 |
| Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 |
Vol. 11 No. 4 |
314 |
| Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration |
Vol. 11 No. 4 |
326 |
| Statistical Analysis of Barrier Isolator/Glovebox Glove Failure |
Vol. 11 No. 4 |
338 |
| PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 |
Vol. 11 No. 4 |
350 |
| Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 |
Vol. 11 No. 3 |
220 |
| Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 |
Vol. 11 No. 3 |
230 |
| Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form |
Vol. 11 No. 3 |
240 |
| PostScription: Lobbying: How It Affects Compounding |
Vol. 11 No. 3 |
262 |
| PreScription: State or Federal Control of Pharmacy Practice |
Vol. 11 No. 3 |
178 |
| PreScription: Putting the Science Back into Pharmacy |
Vol. 11 No. 2 |
92 |
| Certified Diabetes Educator: A Credential for Compounding Pharmacists |
Vol. 11 No. 2 |
112 |
| Records and Record-Keeping for the Hospital Compounding Pharmacist |
Vol. 11 No. 2 |
138 |
| PreScription: IJPC: The Next 10 Years |
Vol. 11 No. 1 |
2 |
| Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 |
Vol. 11 No. 1 |
5 |
| Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding |
Vol. 11 No. 1 |
56 |
| Pharmacogenomics: The End of Trial-and-Error Medicine? |
Vol. 11 No. 1 |
59 |
| PostScription: Challenges Facing an Analytical Laboratory |
Vol. 10 No. 6 |
479 |
| Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists |
Vol. 10 No. 6 |
462 |
| Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination |
Vol. 10 No. 6 |
446 |
| Topical Cidofovir for Treatment of Resistant Viral Infections |
Vol. 10 No. 5 |
324 |
| Education, Training, and Evaluation of Hospital Compounding Personnel |
Vol. 10 No. 5 |
361 |
| Basics of Compounding for Hazardous Drugs, Part 1: An Introduction |
Vol. 10 No. 5 |
377 |
| PreScription: Standards, Legal Standards, and Accreditation |
Vol. 10 No. 3 |
162 |
| Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate |
Vol. 10 No. 3 |
165 |
| The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States |
Vol. 10 No. 3 |
175 |
| Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? |
Vol. 10 No. 3 |
202 |
| Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 |
Vol. 10 No. 3 |
208 |
| PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! |
Vol. 10 No. 3 |
240 |
| PreScription: The Squeaky Wheel Gets the Grease! |
Vol. 10 No. 2 |
82 |
| Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist |
Vol. 10 No. 2 |
113 |
| Pharmaceutical Legislation: An Historical Perspective |
Vol. 10 No. 1 |
20 |
| Pharmacy Compounding Urban Legends |
Vol. 10 No. 1 |
32 |
| Prescription: Pediatric Formulation Initiatives |
Vol. 9 No. 6 |
410 |
| Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America |
Vol. 9 No. 5 |
332 |
| Compounding: A Well-established Practice in 1938 |
Vol. 9 No. 5 |
364 |
| Local Ventilation for Safe Containment in the Pharmaceutical Industry |
Vol. 9 No. 4 |
293 |
| Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products |
Vol. 9 No. 4 |
284 |
| Survey of State Veterinary Compounding Laws and Regulations |
Vol. 9 No. 3 |
209 |
| PostScription: AVMA's Position on Compounding for Animals |
Vol. 9 No. 3 |
247 |
| Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer |
Vol. 9 No. 2 |
93 |
| Standard Operating Procedure: SOP Master Book--Maintenance |
Vol. 9 No. 2 |
145 |
| Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations |
Vol. 9 No. 2 |
127 |
| Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations |
Vol. 9 No. 2 |
136 |
| PostScription: Experts Everywhere |
Vol. 9 No. 2 |
167 |
| The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") |
Vol. 9 No. 1 |
44 |
| Is Veterinary Compounding Illegal Under Federal Law? |
Vol. 8 No. 6 |
449 |
| PostScription: Your voice is important to the future of pharmacy |
Vol. 8 No. 5 |
407 |
| A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards |
Vol. 8 No. 4 |
251 |
| PostScription: Cleanroom Standards |
Vol. 8 No. 2 |
160 |
| PostScription: The Wedgewood Case: What It Means for Pharmacies |
Vol. 8 No. 1 |
79 |
| PreScription: Take Care with Terminology for Altered- and Slow-release Formulations |
Vol. 7 No. 6 |
418 |
| PostScription: Changing Pharmacy Regulations Could Affect US Compounders |
Vol. 7 No. 6 |
495 |
| Application of USP-NF Standards to Pharmacy Compounding |
Vol. 7 No. 5 |
361 |
| HIPAA Privacy and Security for Providers: The Basics |
Vol. 7 No. 4 |
277 |
| Containment of Hazardous Particulates in the Compounding Pharmacy |
Vol. 7 No. 4 |
281 |
| Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics? |
Vol. 7 No. 4 |
320 |
| Legal & Ethical Issues for Pharmacy Websites |
Vol. 7 No. 2 |
88 |
| Regulatory and Operational Issues of Founding a Compounding Pharmacy |
Vol. 6 No. 6 |
434 |
| Medications Discontinued in the United States |
Vol. 6 No. 6 |
441 |
| Compounding and the Courts |
Vol. 6 No. 4 |
263 |
| Facilities and Procedures for Compounding Hazardous Drugs |
Vol. 6 No. 4 |
267 |
| Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer |
Vol. 6 No. 4 |
271 |
| Legal Issues: Technicians in the Compounding Pharmacy Practice |
Vol. 6 No. 4 |
274 |
| Medications Discontinued in the United States |
Vol. 6 No. 4 |
286 |
| Medications Discontinued in the United States |
Vol. 6 No. 3 |
193 |
| Medications Discontinued in the United States |
Vol. 6 No. 2 |
123 |
| Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory |
Vol. 6 No. 2 |
149 |
| Compounding with Controlled Substances |
Vol. 6 No. 1 |
8 |
| The Problem of Drug Diversion |
Vol. 6 No. 1 |
11 |
| Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective |
Vol. 6 No. 1 |
13 |
| PostScription: Regulatory Uncertainty Requires Professional Responsibility |
Vol. 6 No. 1 |
80 |
| Compounding Issues and Accreditation Agencies |
Vol. 5 No. 4 |
273 |
| The American Veterinary Medical Association Compounding Position Statement |
Vol. 5 No. 3 |
216 |
| Establishing and Maintaining a Compounding Pharmacy Reference Library |
Vol. 5 No. 3 |
226 |
| Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding |
Vol. 5 No. 2 |
97 |
| Drugs Banned for Use in Food Animals: An Explanation |
Vol. 5 No. 2 |
101 |
| From Wagon-Era Paregoric to Computer-Era Herbals |
Vol. 5 No. 2 |
112 |
| Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing |
Vol. 5 No. 2 |
140 |
| Assignment of a Beyond-Use Date for Compounded Preparations |
Vol. 4 No .6 |
474 |
| Compounding Using Hazardous Drugs |
Vol. 4 No. 4 |
261 |
| Compounding OTC Drugs: A Legal Perspective |
Vol. 4 No. 3 |
180 |
| Pharmacy Licensure Requirements |
Vol. 4 No. 3 |
184 |
| The Future of Compounding: An Industry Perspective |
Vol. 4 No. 3 |
204 |
| Assignment of Beyond-Use Dates |
Vol. 4 No. 3 |
222 |
| Analytical Testing of Extemporaneously Compounded Preparations |
Vol. 4 No. 2 |
105 |
| When Problem Audits Strike |
Vol. 3 No. 6 |
458 |
| When is Compounding for Animals Legal? |
Vol. 3 No. 3 |
188 |
| Report: USP Expert Advisory Panel on Pharmacy Compounding Practices |
Vol. 3 No. 2 |
126 |
| FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns |
Vol. 3 No. 1 |
25 |
| Opioids for Noncancer Pain: From Controversy to Consensus |
Vol. 2 No. 2 |
106 |
| Firing an Employee - Without Getting Burned |
Vol. 2 No. 2 |
130 |
| FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding |
Vol. 1 No. 6 |
399 |
| Aspirin in Chloroform (Chloroform Banned in US) |
Vol. 1 No. 6 |
407 |
| The Decision to Compound |
Vol. 1 No. 2 |
71 |
| The Compounding Pharmacist |
Vol. 1 No. 2 |
73 |
| NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies |
Vol. 1 No. 2 |
75 |
|
|
|
| BUSINESS RELATED ARTICLES |
| Title (Click for Details) |
Vol/Issue |
Page |
| Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy |
Vol. 22 No. 6 |
471 |
| Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 |
Vol. 22 No. 5 |
401 |
| Compounding from a Pharmacy Student's Perspective |
Vol. 22 No. 4 |
281 |
| Your Presence is Needed at Compounders on Capitol Hill! |
Vol. 22 No. 3 |
204 |
| Pharmacogenomics: Precision Pharmacy in 503A Compounding |
Vol. 22 No. 2 |
95 |
| Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies |
Vol. 22 No. 1 |
7 |
| Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting |
Vol. 21 No. 5 |
384 |
| PreScription: Just Think About It! |
Vol. 21 No. 4 |
268 |
| PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Vol. 21 No. 3 |
180 |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Vol. 21 No. 3 |
212 |
| PreScription: Compounding Pharmacy Issues for 2017 |
Vol. 21 No. 1 |
4 |
| Why Become Pharmacy Compounding Accreditation Board Accredited? |
Vol. 20 No. 6 |
469 |
| Choosing a Vial Processing Line for Aseptic Compounding: Part 1 |
Vol. 20 No. 4 |
283 |
| Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding |
Vol. 20 No. 4 |
307 |
| Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives |
Vol. 20 No. 2 |
114 |
| PostScription: The Home Field Advantage |
Vol. 20 No. 1 |
86 |
| Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States |
Vol. 19 No. 6 |
514 |
| The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding |
Vol. 19 No. 5 |
375 |
| The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists |
Vol. 19 No. 5 |
377 |
| Giving Back: A Win-Win Plan of Action for Compounding Pharmacists |
Vol. 19 No. 1 |
14 |
| Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous |
Vol. 18 No. 6 |
486 |
| PreScription: Challenging Times |
Vol. 18 No. 4 |
268 |
| Effective Advertisements |
Vol. 18 No. 2 |
120 |
| Marketing |
Vol. 18 No. 1 |
38 |
| PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services |
Vol. 18 No. 1 |
87 |
| Compounding Pharmacies: Before and After an Inspection |
Vol. 17 No. 5 |
358 |
| Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach |
Vol. 17 No. 5 |
393 |
| Patient-centered Care as Value-added Service by Compounding Pharmacists |
Vol. 17 No. 4 |
339 |
| PreScription: Compounding for Drug Shortages |
Vol. 17 No. 3 |
180 |
| Optimizing Third-party Reimbursement for Compounded Medications |
Vol. 17 No. 3 |
201 |
| PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial |
Vol. 17 No. 3 |
262 |
| PreScription: Pharmacy Committees |
Vol. 17 No. 2 |
92 |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel |
Vol. 16 No. 6 |
490 |
| Okay, I've Got It: Now What Do I Do With It? |
Vol. 16 No. 4 |
310 |
| Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy |
Vol. 16 No. 3 |
224 |
| Trade Shows: Planning Your Strategy |
Vol. 16 No. 2 |
134 |
| Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need |
Vol. 15 No. 6 |
480 |
| PreScription: Third-party Inequities and Discrimination |
Vol. 15 No. 5 |
356 |
| 7 Marketing Tactics That Don't Work |
Vol. 15 No. 5 |
388 |
| PreScription: Greed Does Not Pay! Makena, Lucentis, and Others |
Vol. 15 No. 3 |
180 |
| PreScription: Making Things Right--Or Not? |
Vol. 15 No. 3 |
180 |
| Seven Marketing Tactics That Don't Work |
Vol. 15 No. 2 |
130 |
| Home Infusion 101 |
Vol. 15 No. 1 |
6 |
| A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management |
Vol. 15 No. 1 |
20 |
| PostScription: Profile of a Pharmacy Compounding Accreditation Board–Accredited Pharmacy: Vital Care of Meridian |
Vol. 15 No. 1 |
86 |
| Home Infusion: Overcoming the Barriers to Entry |
Vol. 14 No. 6 |
450 |
| PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy |
Vol. 14 No. 6 |
531 |
| Quality Control Analytical Methods: Continuous Quality Improvement |
Vol. 14 No. 3 |
218 |
| Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network |
Vol. 14 No. 2 |
134 |
| Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes |
Vol. 14 No. 2 |
124 |
| Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study |
Vol. 13 No. 5 |
440 |
| Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients |
Vol. 13 No. 4 |
290 |
| Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care? |
Vol. 13 No. 4 |
318 |
| PostScription: Compounding in Israel |
Vol. 13 No. 3 |
262 |
| PreScription: A Good Name: Pharmacy |
Vol. 13 No. 3 |
180 |
| Tips for Cleanroom Construction and Renovation |
Vol. 13 No. 2 |
100 |
| Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations |
Vol. 13 No. 2 |
106 |
| Blogging for Business |
Vol. 13 No. 2 |
141 |
| Incorporating Web Communication to Maximize Staff Productivity in a Compounding Pharmacy |
Vol. 13 No. 2 |
138 |
| Technology for the Compounding Pharmacy: Digital Pens--Tools or Toys? |
Vol. 13 No. 1 |
50 |
| PreScription: Compounding Around the World |
Vol. 12 No. 5 |
382 |
| Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers |
Vol. 12 No. 5 |
414 |
| Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? |
Vol. 12 No. 5 |
420 |
| Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations |
Vol. 12 No. 5 |
432 |
| Technology for the Patient-Centric Pharmacy |
Vol. 12 No. 5 |
434 |
| Prescription: Is "Globalization" a Good Idea? |
Vol. 12 No. 6 |
474 |
| Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where |
Vol. 12 No. 6 |
514 |
| Branding: Give Your Small Business a Big Image |
Vol. 12 No. 6 |
537 |
| Web 2.0 and Health 2.0: Are You In? |
Vol. 12 No. 3 |
244 |
| Newsletters: An Essential Marketing Tool |
Vol. 12 No. 2 |
128 |
| PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care |
Vol. 12 No. 2 |
174 |
| Websites: Keeping Current in 2008 |
Vol. 12 No. 1 |
48 |
| Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 |
Vol. 12 No. 1 |
63 |
| Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists |
Vol. 12 No. 1 |
74 |
| The Internet and Its Websites: Your New Business Partner |
Vol. 11 No. 6 |
472 |
| The Whales: A Pharmacist's Story |
Vol. 11 No. 5 |
376 |
| Standard Operating Procedure: Complaint and Mishap Rectification |
Vol. 11 No. 5 |
414 |
| Premarin: The Intriguing History of a Controversial Drug |
Vol. 11 No. 4 |
282 |
| Book Review: The Rexall Story: A History of Genius and Neglect |
Vol. 11 No. 4 |
300 |
| The Politics of Hormone Replacement Therapy |
Vol. 11 No. 4 |
278 |
| Records and Record-Keeping for the Hospital Compounding Pharmacist |
Vol. 11 No. 2 |
138 |
| Information Resources and Software for the Hospital Compounding Pharmacist |
Vol. 11 No. 1 |
36 |
| Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection |
Vol. 11 No. 1 |
50 |
| Compounding In Crisis:The Aftermath of Hurricane Katrina |
Vol. 11 No. 1 |
28 |
| Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding |
Vol. 11 No. 1 |
56 |
| Calculations |
Vol. 11 No. 1 |
68 |
| PostScription: IJPC—More Than a Journal |
Vol. 11 No. 1 |
88 |
| Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists |
Vol. 10 No. 6 |
462 |
| Education, Training, and Evaluation of Hospital Compounding Personnel |
Vol. 10 No. 5 |
361 |
| Basics of Compounding for Hazardous Drugs, Part 1: An Introduction |
Vol. 10 No. 5 |
377 |
| What are You Willing to Do? |
Vol. 10 No. 4 |
287 |
| Quick Tips for Managing Market Directors |
Vol. 10 No. 3 |
201 |
| PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! |
Vol. 10 No. 3 |
240 |
| PreScription: The Squeaky Wheel Gets the Grease! |
Vol. 10 No. 2 |
82 |
| How'd They Do That? |
Vol. 10 No. 1 |
46 |
| Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success |
Vol. 10 No. 1 |
50 |
| Marketing Your Business for Success |
Vol. 9 No. 6 |
445 |
| Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success |
Vol. 9 No. 6 |
452 |
| Back to the Basics of Business |
Vol. 9 No. 5 |
380 |
| Standard Operating Procedure: Employee Personnel Records |
Vol. 9 No. 4 |
309 |
| Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation |
Vol. 9 No. 3 |
173 |
| Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs |
Vol. 9 No. 3 |
201 |
| Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer |
Vol. 9 No. 2 |
93 |
| Standard Operating Procedure: SOP Master Book--Maintenance |
Vol. 9 No. 2 |
145 |
| Communication Makes It or Breaks It |
Vol. 9 No. 2 |
133 |
| The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime |
Vol. 9 No. 1 |
37 |
| Defining Success |
Vol. 9 No. 1 |
42 |
| Book Review: Good to Great: Why Some Companies Make the Leap and Others Don't |
Vol. 8 No. 6 |
412 |
| A Foot in the Door: Marketing Tips - Dealing With Personalities |
Vol. 8 No. 5 |
373 |
| Standard Operating Procedure: Pharmacy Computer System Access to and Maintenance of the Master Formula Records |
Vol. 8 No. 5 |
381 |
| PostScription: Your voice is important to the future of pharmacy |
Vol. 8 No. 5 |
407 |
| PreScription - Categories of Pharmaceutial Compounding |
Vol. 8 No. 4 |
242 |
| A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards |
Vol. 8 No. 4 |
251 |
| Rationale for a Pharmacists' Pharmacopeia |
Vol. 8 No. 4 |
285 |
| PostScription: What is Evidence-Based Medicine? |
Vol. 8 No. 4 |
320 |
| Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor |
Vol. 8 No. 3 |
162 |
| Book and Literature Reviews |
Vol. 8 No. 3 |
164 |
| Compounding in the Pharmacy Curriculum: Beyond the Basics |
Vol. 8 No. 3 |
181 |
| Precepting: A Win-Win Situation for All |
Vol. 8 No. 3 |
194 |
| A Foot in the Door: Building Relationships Builds Your Business |
Vol. 8 No. 3 |
197 |
| Standard Operating Procedure: Disposal of Chemicals |
Vol. 8 No. 3 |
210 |
| Quality-Control Analytical Methods: High-Performance Liquid Chromatography |
Vol. 8 No. 3 |
223 |
| PostScription: How should a pharmacist be trained? |
Vol. 8 No. 3 |
240 |
| Prescription - USP <795>, NABP and the Physician/patient/pharmacist relationship - From the Editor |
Vol. 8 No. 2 |
82 |
| Literature Reviews |
Vol. 8 No. 2 |
84 |
| Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists |
Vol. 8 No. 2 |
89 |
| Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs |
Vol. 8 No. 2 |
101 |
| Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. |
Vol. 8 No. 2 |
107 |
| Detailing Your Compounding Specialty Practice - Part 2: The Presentation |
Vol. 8 No. 2 |
113 |
| Financially Speaking: Business Continuation Planning |
Vol. 8 No. 2 |
120 |
| Calibration/Validation of Incubator Temperature |
Vol. 8 No. 2 |
130 |
| Quality-Control Analytical Methods: Osmolality and Osmometry |
Vol. 8 No. 2 |
143 |
| PostScription: Cleanroom Standards |
Vol. 8 No. 2 |
160 |
| Prescription-Who and/or What is IJPC and the subject of pharmacy practice and compounding pharmacy-From the Editor |
Vol. 8 No. 1 |
2 |
| Book & Literature Reviews |
Vol. 8 No. 1 |
4 |
| Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP |
Vol. 8 No. 1 |
22 |
| Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach |
Vol. 8 No. 1 |
31 |
| Developing and Providing Compounding Services for Hospitals Involved in a Merger |
Vol. 8 No. 1 |
36 |
| American Pharmaceutical Patents From a Historical Perspective |
Vol. 8 No. 1 |
40 |
| Handling of Syringes and Needles |
Vol. 8 No. 1 |
49 |
| Quality-Control Analytical Methods: Selecting an Analytical Method |
Vol. 8 No. 1 |
61 |
| Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy |
Vol. 8 No. 1 |
65 |
| Compounding for Investigational Studies: The Experience of Ken Hughes, RPh |
Vol. 7 No. 6 |
436 |
| Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care |
Vol. 7 No. 6 |
441 |
| A Foot in the Door: Marketing Tips |
Vol. 7 No. 6 |
454 |
| Technology Spotlight: Automated Prescription-Dispensing Systems |
Vol. 7 No. 6 |
458 |
| PostScription: Changing Pharmacy Regulations Could Affect US Compounders |
Vol. 7 No. 6 |
495 |
| Book and Literature Reviews |
Vol. 7 No. 5 |
324 |
| Postcriptions: Compounding Paradox: Taught Less and Practiced More |
Vol. 7 No. 5 |
399 |
| Calculations |
Vol. 7 No. 5 |
372 |
| An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices |
Vol. 7 No. 5 |
401 |
| Book Reviews |
Vol. 7 No. 4 |
244 |
| Literature Review |
Vol. 7 No. 4 |
246 |
| Patient Satisfaction with Pharmacist Intervention and Consultation in HRT |
Vol. 7 No. 4 |
258 |
| HIPAA Privacy and Security for Providers: The Basics |
Vol. 7 No. 4 |
277 |
| Further Clarification of HIPAA Regulations |
Vol. 7 No. 3 |
195 |
| Software for the Compounding Pharmacist: An Update |
Vol. 7 No. 3 |
197 |
| Legal & Ethical Issues for Pharmacy Websites |
Vol. 7 No. 2 |
88 |
| Profile of a Practice: Building a Compounding Pharmacy Practice from the Ground Up: Prescription Compounding Solutions, Medford, Oregon |
Vol. 7 No. 2 |
101 |
| Barcode System and Computerized Balance Speed Compounding and Enhance Accuracy |
Vol. 7 No. 2 |
118 |
| Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center |
Vol. 7 No. 1 |
21 |
| Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 2 |
Vol. 7 No. 1 |
32 |
| Postcription: Future Trends in High Technology Pharmaceutical Compounding |
Vol. 7 No. 1 |
80 |
| The Cost of Quality in Pharmacy |
Vol. 6 No. 6 |
404 |
| Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 |
Vol. 6 No. 6 |
428 |
| Regulatory and Operational Issues of Founding a Compounding Pharmacy |
Vol. 6 No. 6 |
434 |
| Medications Discontinued in the United States |
Vol. 6 No. 6 |
441 |
| Navigating New Territories in Compounding for Veterinary Medicine |
Vol. 6 No. 5 |
324 |
| Rites of Passage |
Vol. 6 No. 5 |
337 |
| Quality in Pharmacy: The New Zealand Experience |
Vol. 6 No. 5 |
354 |
| Third-Party Contracting for Compounding Pharmacies |
Vol. 6 No. 5 |
359 |
| Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy |
Vol. 6 No. 5 |
377 |
| Establishing an Andropause Practice |
Vol. 6 No. 4 |
259 |
| Compounding and the Courts |
Vol. 6 No. 4 |
263 |
| Legal Issues: Technicians in the Compounding Pharmacy Practice |
Vol. 6 No. 4 |
274 |
| Excerpts from and Reviews of Current Published Literature: Pharmacy Administration and Other Topics of Interest |
Vol. 6 No. 4 |
278 |
| Magnetic Iron “Whiskers” in Cereals |
Vol. 6 No. 4 |
281 |
| Medications Discontinued in the United States |
Vol. 6 No. 4 |
286 |
| How To Perform a Study in Your Pharmacy with Little or No Effort |
Vol. 6 No. 3 |
186 |
| Medications Discontinued in the United States |
Vol. 6 No. 3 |
193 |
| pH and Osmolarity, A Review of |
Vol. 6 No. 3 |
216 |
| Developing Standard Operating Procedures |
Vol. 6 No. 3 |
224 |
| Developing a Successful Compounding Business in a Small Town |
Vol. 6 No. 2 |
108 |
| A Guide to Effective Media Relations |
Vol. 6 No. 2 |
111 |
| Medications Discontinued in the United States |
Vol. 6 No. 2 |
123 |
| Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory |
Vol. 6 No. 2 |
149 |
| Compounding with Controlled Substances |
Vol. 6 No. 1 |
8 |
| The Problem of Drug Diversion |
Vol. 6 No. 1 |
11 |
| Team Building For Success |
Vol. 6 No. 1 |
27 |
| Safety for Employees in the Compounding Work Area |
Vol. 6 No. 1 |
60 |
| High-tech Compounding: State-of-the-art Equipment Improves Products and Profit |
Vol. 5 No. 6 |
412 |
| High-tech Rx Compliance |
Vol. 5 No. 6 |
419 |
| High-tech Marketing Techniques |
Vol. 5 No. 6 |
420 |
| Training Personnel |
Vol. 5 No. 6 |
474 |
| Compounding Issues and Accreditation Agencies |
Vol. 5 No. 4 |
273 |
| Analytical Testing Facilities and Products |
Vol. 5 No. 4 |
284 |
| Formulations for Success, Part 2 |
Vol. 5 No. 4 |
287 |
| Motivation and Management: How to Build Your Business into the Job You Love |
Vol. 5 No. 3 |
166 |
| A New Trend in Pharmacy Practice: Private Consultations |
Vol. 5 No. 3 |
170 |
| Formulations for Success in Compounding, Part 1 |
Vol. 5 No. 3 |
174 |
| Developing a Business Plan for a Compounding Specialty Pharmacy |
Vol. 5 No. 3 |
176 |
| Pricing Strategies |
Vol. 5 No. 3 |
180 |
| The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees |
Vol. 5 No. 3 |
182 |
| Book Reviews: Business Topics for Compounding Pharmacists |
Vol. 5 No. 3 |
185 |
| Software for the Compounding Pharmacist: A Review |
Vol. 5 No. 3 |
187 |
| Compounding in History: Compounding Economics |
Vol. 5 No. 3 |
196 |
| Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective |
Vol. 5 No. 3 |
221 |
| Establishing and Maintaining a Compounding Pharmacy Reference Library |
Vol. 5 No. 3 |
226 |
| Profile of a Practice: Custom Rx Compounding and Natural Pharmacy |
Vol. 5 No. 2 |
118 |
| Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing |
Vol. 5 No. 2 |
140 |
| Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding |
Vol. 5 No. 2 |
147 |
| Profile of a Practice |
Vol. 5 No. 1 |
32 |
| Sterile-Product Preparations: Mix or Buy? |
Vol. 5 No. 1 |
59 |
| On-Line Billing for Custom Compounds: The Third-Party Payor |
Vol. 4 No .6 |
445 |
| Profile of a Practice: Med Specialties Pharmacy |
Vol. 4 No .6 |
448 |
| Profile of A Practice: Hormone Replacement Therapy in the Heartland |
Vol. 4 No. 5 |
362 |
| Profile of a Practice |
Vol. 4 No. 4 |
287 |
| Pharmacy Licensure Requirements |
Vol. 4 No. 3 |
184 |
| Profile of a Practice: Surviving the Competition |
Vol. 4 No. 3 |
203 |
| The Future of Compounding: An Industry Perspective |
Vol. 4 No. 3 |
204 |
| Marketing Your Prescription Compounding Practice: Part Two |
Vol. 4 No. 2 |
115 |
| Profile of a Practice |
Vol. 4 No. 2 |
120 |
| Marketing Your Prescription Compounding Practice: Part One |
Vol. 4 No. 1 |
36 |
| Marketing Tip: Marketing Reps Can Help |
Vol. 4 No. 1 |
39 |
| Profile of a Practice |
Vol. 4 No. 1 |
40 |
| Calibration of Hot Plates |
Vol. 4 No. 1 |
65 |
| Profile of a Practice: Going the Extra Mile with Pharmaceutical Care |
Vol. 3 No. 6 |
455 |
| Independent Pharmacists Score High with Consumers |
Vol. 3 No. 6 |
457 |
| When Problem Audits Strike |
Vol. 3 No. 6 |
458 |
| Finding the Balance |
Vol. 3 No. 5 |
340 |
| Compounding Practice Structures |
Vol. 3 No. 5 |
368 |
| Closing in on 2000: Your Y2K Report |
Vol. 3 No. 5 |
371 |
| Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding |
Vol. 3 No. 4 |
253 |
| Profile of a Practice |
Vol. 3 No. 4 |
288 |
| Improving Profitability with Veterinary Compounding |
Vol. 3 No. 3 |
180 |
| Value and Pricing: Figuring Out What You're Worth |
Vol. 3 No. 3 |
197 |
| The BPS Pharmacy Specialty Certification Program |
Vol. 3 No. 3 |
200 |
| Profile of a Practice |
Vol. 3 No. 2 |
116 |
| Personal Computing: Take Care When Choosing a Computer Consultant |
Vol. 3 No. 2 |
122 |
| Report: USP Expert Advisory Panel on Pharmacy Compounding Practices |
Vol. 3 No. 2 |
126 |
| Issues and Opportunities: Compounding for Dentistry |
Vol. 3 No. 1 |
4 |
| Audit Problems for Compounding Pharmacies |
Vol. 3 No. 1 |
36 |
| HRT Marketing Tip |
Vol. 3 No. 1 |
37 |
| Profile of a Practice |
Vol. 3 No. 1 |
39 |
| Physical Requirements for a Nuclear Pharmacy |
Vol. 2 No. 6 |
426 |
| Comparison of Job Satisfaction for Compounders and Noncompounders |
Vol. 2 No. 6 |
455 |
| Required Documentation for Home Infusion Pharmacies - Compounding Records |
Vol. 2 No. 5 |
354 |
| Third Party Contracts and the Compounding Pharmacy |
Vol. 2 No. 4 |
286 |
| A Glimpse Into the Future |
Vol. 2 No. 3 |
203 |
| An Eye to Success |
Vol. 2 No. 3 |
205 |
| Profile of a Practice: Office Practice Facilitates Compounding and Patient Counseling |
Vol. 2 No. 3 |
219 |
| Firing an Employee - Without Getting Burned |
Vol. 2 No. 2 |
130 |
| Problems with Third-Party Payments for Compounded Prescriptions |
Vol. 2 No. 2 |
134 |
| Hiring Good People |
Vol. 2 No. 1 |
38 |
| PostScription: Independent Pharmacy: Alive and Well |
Vol. 2 No. 1 |
96 |
| FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding |
Vol. 1 No. 6 |
399 |
| What Makes Pharmacists Different? |
Vol. 1 No. 4 |
214 |
| Building a Compounding Lab: Remodeling an Existing Facility or Starting from Scratch? |
Vol. 1 No. 3 |
156 |
| Patient Handouts |
Vol. 1 No. 3 |
160 |
| The Decision to Compound |
Vol. 1 No. 2 |
71 |
| The Compounding Pharmacist |
Vol. 1 No. 2 |
73 |
| NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies |
Vol. 1 No. 2 |
75 |
| PostScription: Growing the Tree of Pharmacy |
Vol. 1 No. 2 |
136 |
| Hospice Care and the Pharmacist |
Vol. 1 No. 1 |
11 |
| The Ten Basic Steps in Filling a Prescription: Then and Now |
Vol. 1 No. 1 |
14 |
| An Ancient Heritage Beckons Pharmacists |
Vol. 1 No. 1 |
22 |
| Electronic Balance Maintenance/Calibration |
Vol. 1 No. 1 |
45 |
| General Guidelines for Use of Chemicals for Prescription Compounding |
Vol. 1 No. 1 |
46 |
| PostScription: The 90s Pharmacist |
Vol. 1 No. 1 |
64 |
